Bausch Health Co. Inc. (NYSE: BHC) reported Q3 EPS of ($0.23), $1.26 worse than the analyst estimate of $1.03. Revenue for the quarter came in at $2.51 billion versus the consensus estimate of $2.42 billion.

GUIDANCE:

Bausch Health Co. Inc. sees FY2024 revenue of $9.5-9.675 billion, versus the consensus of $9.489 billion.

For earnings history and earnings-related data on Bausch Health Co. Inc. (BHC) click here.